Industry Updates

The Year's Best Venous Trials

SINCE I EMBARKED on learning more about venous disease over ten years ago, I’ve been impressed by how much we have yet to grasp. This fascinating field is subject to the same foibles that exist elsewhere. Groupthink...Continue Reading

THROMBOLEX Receives Enhanced Indication for Use from the FDA, related to restoration of blood flow during Catheter Directed Thrombolysis (CDT) treatment

NEWS PROVIDED BYTHROMBOLEXTM, INC.June 30, 2021 The U.S. Food and Drug Administration (FDA) has enhanced the Indications for Use for the BASHIR™ Endovascular Catheter and the BASHIR™ Plus Endovascular Catheter...Continue Reading

Lipedema and Lipolymphedema: New ICD-10-CM Codes Proposed to Enhance Diagnosis, Treatment, and Research

IN JUNE 2020, the Lipedema ICD-10-CM Committee, with support from the American Vein & Lymphatic Society (AVLS), submitted an application to the US Centers for Disease Control and Prevention to establish new ICD-10-CM...Continue Reading

AVLS PRO Venous Registry: 2.0 Goes Live!

THE AMERICAN Vein & Lymphatic Society and Joe Jenkins, MD, FACS, RPVI, RPhS, RVT, DABVLM, CWSP, Chair of the PRO Registry Operations Committee are excited to announce the completion of the new PRO Venous Registry 2.0...Continue Reading

Venous Symposium Goes Virtual

FOR THE PAST 10 years the Venous Symposium (VS) has delivered the most practical education on the treatment of venous disease. Although the circumstances of COVID-19 forced VS to host a virtual conference, VS was committe...Continue Reading

First Patient Enrolled in the RESCUE Trial for Treatment of Acute Submassive Pulmonary Embolism

New Britain, PA. August 6, 2020 - THROMBOLEX™ Inc. has announced that it has enrolled the first patient in its pivotal RESCUE trial for the treatment of patients with acute submassive pulmonary embolism (PE) using...Continue Reading

SIR Reimagines Annual Conference Due to COVID-19

With their annual conference slated for March 2020, the leadership of the Society of Interventional Radiology (SIR) had no government orders to guide them. Here’s a look at their extraordinary circumstances, how th...Continue Reading

Appropriate Use: The Wall Street Journal Gets It. Do we?

By Elna Masuda and Steve Elias In September 2019, the Wall Street Journal published an article entitled “Overuse of stenting in arteries in the leg.”1 As a result, a flurry of responses followed in the Society...Continue Reading

Undertreatment of Venous Disease: A Novel Concept

by Marlin Schul This article is adapted from Dr. Marlin Schul's American Vein & Lymphatic Society (AVLS) Presidential Address given at the 2019 AVLS Annual Congress We have spent a lot of time discussing the overutil...Continue Reading

Improving the Care of Venous Patients using a Coordinated Registry Network

By Jens Eldrup-Jorgensen MD, Danica Marinac-Dabic MD, Marlin W. Schul MD, PhD, Art Sedrakyan MD The Institute of Medicine defines the quality of care as the degree to which health care services for individuals and popula...Continue Reading